Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 7/6/2016 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Arthur Sands?

Arthur T. Sands

Chief Executive Officer

Nurix , Inc.

HQ Phone:  (415) 660-5320

Direct Phone: (415) ***-****direct phone

Email: a***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Nurix , Inc.

1700 Owens Street, Suite 205

San Francisco, California,94158

United States

Company Description

Nurix, Inc. is a leader in the discovery of small molecules that modulate the ubiquitin proteasome system (UPS) to address significant, unmet medical needs. The UPS is a regulatory pathway that controls protein levels, a function vital to the healthy life of a... more

Find other employees at this company (63)

Background Information

Employment History

Chief Executive Officer and President

Lead411


President and Chief Executive Officer

Lexicon Pharmaceuticals Inc


Affiliations

Additional

Board Member


Texas Institute for Genomic Medicine

Board Member


Symphony Icon Inc

Board Member


Third Rock Ventures LLC

Chairman of Board of Directors


American Cancer Society Inc

Postdoctoral Fellow In the Department of Human and Molecular Genetics


Education

B.A.

economics and political science

Yale University


M.S.


Ph.D


Ph.D.

Baylor College of Medicine


Web References(154 Total References)


Nurix | Management Team

www.nurix-inc.com [cached]

Arthur T. Sands, M.D., Ph.D.
Chief Executive Officer and Board Director Arthur T. Sands, M.D., Ph.D., serves as the Chief Executive Officer at Nurix and is a member of the company's board of directors. Prior to joining Nurix, Dr. Sands co-founded Lexicon Pharmaceuticals and served as President, Chief Executive Officer and a Director since 1995. At Lexicon, Dr. Sands pioneered the development of large-scale gene knockout technology for use in drug discovery and guided the evolution of Lexicon from a research-stage company to a drug development company, catalyzed by numerous alliances with Bristol Myers Squibb, Takeda and Genentech, and generating more than $450 million in revenue. Dr. Sands serves as Adjunct Professor in the Department of Human and Molecular Genetics at Baylor College of Medicine. He has also published many scientific and medical articles and is an inventor on numerous patents related to the discovery of human genes and their use in the development of new therapies. Dr. Sands holds an M.D. and a Ph.D. from Baylor College of Medicine and a B.A. in economics and political science from Yale University.


Board of Directors - BioHouston

www.biohouston.org [cached]

Arthur T. Sands M.D., Ph.D., CEO, Nurix, Inc.


www.talent4boards.com

"It is indeed a privilege to welcome Dr. Tjian to the Nurix board of directors," said Arthur T. Sands, M.D., Ph.D., chief executive officer of Nurix.
"Dave has made significant contributions to Nurix since its inception and has been a guiding influence for the advancement of Nurix's scientific and business initiatives, said Dr. Sands. Nurix announces Arthur Sands to Board as incoming CEO


Nurix Announces New Appointments to Its Board of Directors | Business Wire

feeds.businesswire.com [cached]

Both David and Perry have distinguished careers in building and leading large R&D organizations and bring abundant operating experience that will help propel our drug discovery platform," said Arthur T. Sands, M.D., Ph.D., CEO of Nurix.
"As Nurix's interim CEO and director, Mark has been a tireless advocate for the advancement of Nurix's scientific and business initiatives, establishing the company as a leader in the protein homeostasis field," said Dr. Sands.


www.contractpharma.com

"Given its global leadership position in the UPS field, Celgene is the ideal partner for Nurix to fully realize the potential of our unique drug discovery engine for small molecule activators and inhibitors of E3 ubiquitin ligases and E2 conjugating enzymes," said Arthur T. Sands, chief executive officer of Nurix.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory